Sort
48,018 grants matching “immunotherapy”
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$374,578Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · CA
Molecular Mechanisms Controlling NK Receptors
$374,562Charles T. Lutz · University Of Kentucky · R01 · FY2010 · AI
Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment
$374,519Brian Koss · Univ Of Arkansas For Med Scis · DP5 · FY2023 · OD
Computational pathology software for integrative cancer research with three-dimensional digital slides
$374,477Jun Kong · Georgia State University · U01 · FY2020 · CA
A Molecular Study of the Gonococcal Transferrin Receptor
$374,475Cynthia Nau Cornelissen · Virginia Commonwealth University · R01 · FY2007 · AI
Novel ways to prevent upper GT infection
$374,453Kathleen A. Kelly · University Of California Los Angeles · R01 · FY2011 · AI
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
$374,438James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$374,436Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2022 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,436Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
Project 2: Optimizing patient selection and deintensified therapy for human papillomavirus positive (HPV+) oropharyngeal cancer (OPC)
$374,423Heath Devin Skinner · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,388Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$374,372Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2022 · CA
eDyNAmiC-TEXASSW
$374,366Zhijian J Chen · Ut Southwestern Medical Center · OT2 · FY2024 · CA
Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment
$374,355Brian Koss · Univ Of Arkansas For Med Scis · DP5 · FY2024 · OD
THERAPEUTIC STUDIES--DENDRITIC CELL BASED CANCER VACCINE
$374,333H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2004 · CA
MAINLINE HEALTH CCOP
$374,190Lankenau Institute For Medical Research · U10 · FY2003 · CA
Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment
$374,185Brian Koss · Univ Of Arkansas For Med Scis · DP5 · FY2025 · OD
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
$374,169David McDermott · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Ricin-Mechanism, Transition State and Inhibitor Design
$374,122Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2009 · CA
Pathway Specific Imaging in VHL Deficient Renal Cancer
$374,110Pankaj K Seth · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
TLR7/8 agonist design and delivery for effective anticancer immune response
$374,075Jayanth Panyam · Temple Univ Of The Commonwealth · R01 · FY2021 · CA
Melanoma immunotherapy targeting sentinel lymph nodes
$374,018Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2016 · CA
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$374,006Franck Housseau · Johns Hopkins University · R01 · FY2017 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$374,006Bo Li · Ut Southwestern Medical Center · R01 · FY2020 · CA
Hematopoietic Stem Cell-based CAR Macrophage for Alzheimer's Disease
$374,000Anjie Zhen · University Of California Los Angeles · R61 · FY2025 · AG